Beximco Profit Tumble Continues Amid Hostile Macro Climate
Company Continues To Deliver Revenue Growth Alongside Profit Decline
Beximco faced another quarter of declining profits despite growing revenue, as external headwinds including increased production costs took their toll on the firm.
You may also be interested in...
In the third part of this year’s Generics Bulletin Top 50, we look at how various increases and declines for companies at the bottom of our table have affected their positions in the ranking.
Following a year of impressive business developments, economic developments such as a depreciating local currency threaten to knock Beximco off-course.
While it currently sits in fourth place, Amneal’s co-CEO Chirag Patel has laid out ambitions for the firm to become the number one supplier of affordable medicines in the US.